ArticleNature communications2026
Molecular evolution and spatial transmission of severe fever with thrombocytopenia syndrome virus.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Establishment and application of a multiplex qPCR panel for multi-host surveillance of tick-Borne pathogens.Emerging microbes & infections · 2026Article
- Phylogeographic epidemiology of Dabie bandavirus in East Asia: divergent transmission networks and genotype‑linked clinical severity.Infectious diseases of poverty · 2026Article
- Genotype-Specific Amino Acid Signatures in the Gn/Gc Glycoprotein of Severe Fever with Thrombocytopenia Syndrome Virus Associated with Neurological Symptoms.Pathogens (Basel, Switzerland) · 2026Article
- Antibody engineering for SFTS treatment: frontier progress and translational challenges.Frontiers in microbiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
Abstract
Severe fever with thrombocytopenia syndrome virus (SFTSV), an emerging pathogen from the family Phenuiviridae, poses severe threats to public health in East Asia. In this study, we elucidate SFTSV's epidemiological dynamics, transmission patterns, and molecular determinants of virulence, through analysis of 1942 genomes obtained from multiple host species across endemic regions in China, South Korea, Japan, and Thailand (2005-2023). Phylogenetic reconstruction delineates two major lineages (L1-Chinese and L2-Japanese-Korean) comprising 13 genotypes (I-XIII). Viral diversity is shaped by extensive segment-specific reassortment (212 events, including L1-L1, L2-L2, and L1-L2 patterns) and recombination (69 events, 62 in China). The M segment exhibited significantly elevated recombination frequency compared to the L and S segments. Geographically, Hubei province in China emerges as a reassortment hotspot with exceptional genotype diversity, while Henan, Hubei, and Zhejiang provinces serve as key recombination centers. Bayesian phylogeographic analysis traces the origin of SFTSV to the Jiangsu-Anhui border region (~17th century). Subsequent spread occurred through two distinct transmission networks: the L1 lineage disseminated terrestrially from Jiangsu-Anhui/Shandong to the Dabie Mountains and Liaoning province, while the L2 lineage dispersed via marine routes, with South Korea acting as a key transmission hub. Integration of clinical data identifies five positively selected sites and mortality-associated co-mutation networks that are enriched in the genotype IV, which is associated with mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.